Pursuing FDA regulatory clearance for AppyScore™
Company: Riot
The claim, verbatim
The company is pursuing receipt of regulatory clearance for and commercialization of AppyScore™, its blood-based diagnostic test for appendicitis
Source (primary)
Riot DEF 14A filed 2012-10-15 (SEC EDGAR, sec_filing)
View cached copy (2026-09-27)Live source ↗
Quote: “pursuit of receipt of regulatory clearance for and commercialization of the Company's blood-based diagnostic test to aid emergency room physicians and other practitioners in the identification of patients at low risk for acute appendicitis”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Riot DEF 14A filed 2012-10-15
Quote: “pursuit of receipt of regulatory clearance for and commercialization of the Company's blood-based diagnostic test to aid emergency room physicians and other practitioners in the identification of patients at low risk for acute appendicitis”